[阿托皮炎的当代管理:从基本的护肤到有针对性的全身疗法]
Claudia Lang1,2, Matthias Möhrenschlager3, Peter Schmid-Grendelmeier1,3,4
1Allergiestation, Dermatologische Klinik, Universitätsspital, Zürich.
Therapeutische Umschau. Revue therapeutique
|October 1, 2025
概括
针对阿托皮性皮炎 (AD) 的新疗法提供了更好的选择. 本综述涵盖了当前的局部和全身疗法,包括生物药物和JAK抑制剂,用于治疗这种慢性皮肤疾病.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
背景情况:
- 无氧性皮肤炎 (AD) 是一种慢性炎症性皮肤疾病,其特征是,湿疹和皮肤屏障受损.
- 最近的治疗进展包括新的局部和全身治疗.
- 目前的管理包括基本护理,局部类固醇,氨酸抑制剂,生物药物和氏激酶 (JAK) 抑制剂.
研究的目的:
- 为提供基于证据的阿托皮性皮肤炎治疗选择的最新概述.
- 讨论现有和新兴AD治疗的疗效和安全性.
- 提供对阿尔茨海默病治疗未来方向的见解.
主要方法:
- 对阿尔茨海默病的当前治疗策略进行了全面的文献综述.
- 对各种治疗方式的疗效和安全数据的分析.
- 综合有关个性化,基于水平的治疗选择的信息,考虑到疾病严重程度,并发症和患者偏好.
主要成果:
- 有一系列的局部和全身疗法可用于AD管理.
- 生物药物和JAK抑制剂代表了严重的AD病例的重大进展.
- 治疗选择是根据疾病严重程度和患者因素进行个性化的.
结论:
- 针对阿托皮性皮肤炎的治疗场景已经显著扩大.
- 个性化治疗方法对于最佳的AD管理至关重要.
- 目前正在进行的研究有望在治疗这种慢性皮肤疾病方面取得进一步进展.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868


